BioLine RX News

News

Тикер

BLRX.TA

ISIN

IL0011015182

Prihod Neto dobit P/E P/S EBIT Dividenda Direktori poslovanja Akcije Tržišna kapitalizacija Dug Obaveze Kapital AAQS Zaposleni ROE ROA ROCE News Dokumenti

BioLine RX Eulerpool новости

BioLine RX vijesti o dionici

BioLine RX je u fokusu novinara i investitora diljem svijeta. Najnovije BioLine RX vijesti prikupljamo ovdje.

20. март ·
Benzinga
Top Wall Street Forecasters Revamp BioLineRx Expectations Ahead Of Q4 Earnings
26. фебруар ·
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
23. фебруар ·
Benzinga
Arbitrator Issues Final Award To BioLineRx, Denies All Claims By Biokine Therapeutics; Biokine To Pay Expenses And Legal Fees
29. новембар ·
Yahoo
BioLine Rx Ltd (BLRX) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Financial ...
25. новембар ·
Yahoo
BLRX: Stem Cell Mobilization Presentation at ASH
24. новембар ·
Yahoo
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
24. новембар ·
SeekingAlpha
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript
18. новембар ·
Yahoo
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
17. новембар ·
Yahoo
BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types
30. септембар ·
Yahoo
BLRX: A Venture into GBM

BioLine RX priopćenja za javnost o dionici

BioLine RX redovito objavljivuje vijesti na web-mjestu tvrtke relevantne za investitore.

BioLine RX News 2026

Ova stranica sadrži sve trenutne vijesti, analizu i prensima za BioLine RX akciju (BLRX.TA, ISIN: IL0011015182). To uključuje Eulerpool vijesti, analizu kompanije i službene prenosima. Podaci se redovito ažuriraju kako bi investitorima pružili potpun pregled najnovijih razvoja u BioLine RX.

BioLine RX Akcija

BioLine RX BioLine RX Ltd is a global biopharmaceutical company specializing in the development of novel therapies for cancer and other serious diseases. The company is headquartered in Israel and has offices in the United States and Europe.